HonCode

Go Back   HER2 Support Group Forums > Clinical Trials
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 06-08-2006, 12:43 PM   #1
StephN
Senior Member
 
StephN's Avatar
 
Join Date: Nov 2004
Location: Misty woods of WA State
Posts: 4,128
Thumbs up New vaccine - patients stage III or in remission

Like me some of the others out there have had trouble qualifying for the HER2 vaccine trials (and I am right here in Seattle!). Tried for the peptide trial and had the wrong HLA number. Tried for the DNA based trial and have a positive ANA (inflammation) reponse which disqualified me.

NOW Patty F at the U of W sends me word of yet another vaccine trial. This is not for HER2 specific cancers but has another target so is open to others NOT Her2 positive.

The TROVAX vaccine will begin a phase II study the end of summer. It is not specifically a HER2 target, but works against 5T4, something common to tumors of various origins.
Only thing is :
"This phase II trial is studying how well vaccine therapy works in treating patients with stage IIIB or stage IV breast cancer in remission."

Remission is required for this Trovax study and at this time I qualify. The trial criteria says that bone mets is the only qualifier, but Patty says that has been changed and the patient can have had mets anywhere and qualify. They are updating the wording.
If interested check this link:
http://www.clinicaltrials.gov/ct/show/NCT00227474?order=1
__________________
"When I hear music, I fear no danger. I am invulnerable. I see no foe. I am related to the earliest times, and to the latest." H.D. Thoreau
Live in the moment.

MY STORY SO FAR ~~~~
Found suspicious lump 9/2000
Lumpectomy, then node dissection and port placement
Stage IIB, 8 pos nodes of 18, Grade 3, ER & PR -
Adriamycin 12 weekly, taxotere 4 rounds
36 rads - very little burning
3 mos after rads liver full of tumors, Stage IV Jan 2002, one spot on sternum
Weekly Taxol, Navelbine, Herceptin for 27 rounds to NED!
2003 & 2004 no active disease - 3 weekly Herceptin + Zometa
Jan 2005 two mets to brain - Gamma Knife on Jan 18
All clear until treated cerebellum spot showing activity on Jan 2006 brain MRI & brain PET
Brain surgery on Feb 9, 2006 - no cancer, 100% radiation necrosis - tumor was still dying
Continue as NED while on Herceptin & quarterly Zometa
Fall-2006 - off Zometa - watching one small brain spot (scar?)
2007 - spot/scar in brain stable - finished anticoagulation therapy for clot along my port-a-catheter - 3 angioplasties to unblock vena cava
2008 - Brain and body still NED! Port removed and scans in Dec.
Dec 2008 - stop Herceptin - Vaccine Trial at U of W begun in Oct. of 2011
STILL NED everywhere in Feb 2014 - on wing & prayer
7/14 - Started twice yearly Zometa for my bones
Jan. 2015 checkup still shows NED
2015 Neuropathy in feet - otherwise all OK - still NED.
Same news for 2016 and all of 2017.
Nov of 2017 - had small skin cancer removed from my face. Will have Zometa end of Jan. 2018.
StephN is offline   Reply With Quote
Old 06-08-2006, 02:16 PM   #2
Lolly
Senior Member
 
Lolly's Avatar
 
Join Date: Aug 2001
Location: Oregon
Posts: 1,756
THANK YOU Steph; I was telling a Herceptin buddy at my clinic about this trial just yesterday, and will print out the info from the link for her.
Lolly is offline   Reply With Quote
Old 11-09-2006, 06:59 PM   #3
Lolly
Senior Member
 
Lolly's Avatar
 
Join Date: Aug 2001
Location: Oregon
Posts: 1,756
More on TroVax Vaccine Trial...

I spoke with Patty Fintak today, and those interested in this study should contact her to determine if they might qualify. Enrollment should start early next year.

Patty Fintak, Research Coordinator with the Tumor Vaccine Group, UW/Seattle
(206) 543-6620 or e-mail paf3@u.washington.edu

The trial isn't posted on UW's web site yet.
Here's a link from a news bulletin about the group sponsoring the trial, along with a link:

SOUTHWEST ONCOLOGY GROUP TO START PHASE II TRIAL OF OXFORD BIOMEDICA'S TROVAX IN BREAST CANCER

- Regulatory clearance for start of patient recruitment in 120-patient Phase II trial of TroVax in patients with late-stage breast cancer -
http://www.oxfordbiomedica.co.uk/news/2006-ob-18.htm

"Oxford BioMedica (LSE: OXB), a leading gene therapy company, announces that the Southwest Oncology Group (SWOG), a US clinical trials cooperative group, has received regulatory clearance to commence a Phase II trial of Oxford BioMedica’s cancer immunotherapy, TroVax, in patients with late-stage breast cancer..."
Lolly is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 04:31 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter